Li, R.; Shokri, F.; Rincon, A.L.; Rivadeneira, F.; Medina-Gomez, C.; Ahmadizar, F.
Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes 2023, 14, 1572.
https://doi.org/10.3390/genes14081572
AMA Style
Li R, Shokri F, Rincon AL, Rivadeneira F, Medina-Gomez C, Ahmadizar F.
Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes. 2023; 14(8):1572.
https://doi.org/10.3390/genes14081572
Chicago/Turabian Style
Li, Ruolin, Fereshteh Shokri, Alejandro Lopez Rincon, Fernando Rivadeneira, Carolina Medina-Gomez, and Fariba Ahmadizar.
2023. "Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review" Genes 14, no. 8: 1572.
https://doi.org/10.3390/genes14081572
APA Style
Li, R., Shokri, F., Rincon, A. L., Rivadeneira, F., Medina-Gomez, C., & Ahmadizar, F.
(2023). Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes, 14(8), 1572.
https://doi.org/10.3390/genes14081572